Internal Medicine, Hematology & Oncology · Boca Raton, FL
NPI
1245227818
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
6200 N Federal Hwy
Boca Raton, FL, 33487
Phone (561) 997-8991
Groups this clinician bills Medicare through
Medicare paid, 2024
$872K
71,344 services
Medicare patients, 2024
553
Average age 76
Drug cost, 2024
$2.0M
2,232 prescriptions
Company payments, 2025
$1,882
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fernando O Recio was code J9271 (injection, pembrolizumab, 1 mg), 19,000 times for 14 patients. In total Fernando O Recio billed 71,344 services in 106 codes, and Medicare paid $872K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-12-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 19,000 | 14 | $0.01 | $148 |
| J9267 Injection, paclitaxel, 1 mg | Office | 15,550 | 15 | $0.08 | $1,211 |
| J9035 Injection, bevacizumab, 10 mg | Office | 7,553 | 14 | $57.38 | $433K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,710 | 26 | $0.09 | $152 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,304 | 26 | $0.07 | $95.34 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 1,189 | 32 | $0.52 | $614 |
| 99214 Office E&M - Established | Office | 1,081 | 506 | $95.67 | $103K |
| J9045 Injection, carboplatin, 50 mg | Office | 658 | 17 | $2.70 | $1,776 |
| 36415 Venipuncture Blood Collection | Office | 652 | 152 | $8.65 | $5,640 |
| J7060 5% dextrose/water (500 ml = 1 unit) | Office | 518 | 31 | $1.41 | $732 |
| 85025 Blood Count | Office | 474 | 45 | $7.61 | $3,607 |
| 96415 Chemotherapy Administration | Office | 366 | 26 | $22.45 | $8,218 |
| 96375 Injection Administration | Office | 313 | 26 | $12.11 | $3,791 |
| 96367 Intravenous Infusion, Hydration | Office | 311 | 25 | $22.20 | $6,905 |
| Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 279 | 279 | $44.57 | $12K |
By year: 2022 $817K for 50,826 services; 2023 $695K for 51,541 services; 2024 $872K for 71,344 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 652 | 152 | $8.65 | $5,640 |
| 85025 Blood Count | 474 | 45 | $7.61 | $3,607 |
| 81002 Clinical Chemistry | 80 | 44 | $3.41 | $273 |
Medicare prescription drug claims, 2024
In 2024, the drug Fernando O Recio prescribed most often to Medicare patients was Estradiol, with 326 prescriptions and refills. In total Fernando O Recio wrote 2,232 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 326 | 914 | 173 | $17K |
| Dexamethasone Generic | 170 | 170 | 47 | $1,670 |
| Aprepitant Generic | 163 | 164 | 40 | $61K |
| Metronidazole Generic | 97 | 97 | 87 | $265 |
| Carboplatin Generic | 91 | 91 | 14 | $3,641 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 87 | 93 | 57 | $1,492 |
| Fluconazole Generic | 84 | 84 | 50 | $351 |
| Paclitaxel Generic | 82 | 82 | 16 | $5,140 |
| Clobetasol Propionate Generic | 77 | 96 | 48 | $1,830 |
| Letrozole Generic | 76 | 180 | 28 | $1,836 |
| Ondansetron Odt Ondansetron | 73 | 76 | 47 | $1,913 |
| Keytruda Pembrolizumab | 69 | 69 | Under 11 | $771K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 47 | 47 | 46 | $236 |
| Alprazolam Generic | 45 | 53 | 17 | $245 |
| Jemperli Dostarlimab-Gxly | 29 | 29 | Under 11 | $354K |
Brand drugs: 226 claims; generic drugs: 2,006 claims; opioid claims: 80.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fernando O Recio $1,882 ($1,882 in general payments such as food, travel and fees) from 15 companies. The largest payer was Intuitive Surgical, Inc. with $500.
| Company | Payments | Amount |
|---|---|---|
| Intuitive Surgical, Inc. ISRG | 1 | $500 |
| GlaxoSmithKline, LLC. GSK | 13 | $274 |
| Pfizer Inc. PFE | 9 | $231 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $163 |
| Eisai Inc. 4523.T | 7 | $156 |
| Merck Sharp & Dohme LLC MRK | 4 | $97.81 |
| CooperSurgical, Inc. COO | 2 | $96.1 |
| Caris MPI, Inc. | 3 | $86.08 |
| Astellas Pharma US Inc 4503.T | 2 | $65.49 |
| Abbvie Inc. ABBV | 2 | $58.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.